This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
De Kouchkovsky I, Abdul-Hay M. Acute myeloid leukemia: A comprehensive review and 2016 update. Blood Cancer J. 2016; 6(7): e441.DeKouchkovsky IAbdul-HayMAcute myeloid leukemia: A comprehensive review and 2016 updateBlood Cancer J201667e44110.1038/bcj.2016.50Search in Google Scholar
Lin P, Falini B. Acute myeloid leukemia with recurrent genetic abnormalities other than translocations. Am J Clin Pathol. 2015; 144(1): 19-28.LinPFaliniBAcute myeloid leukemia with recurrent genetic abnormalities other than translocationsAm J Clin Pathol20151441192810.1309/AJCP97BJBEVZEUINSearch in Google Scholar
Schnittger S, Schoch C, Dugas M. Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: Correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease. Blood. 2002; 100(1): 59-67.SchnittgerSSchochCDugasMAnalysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: Correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual diseaseBlood20021001596710.1182/blood.V100.1.59Search in Google Scholar
Li GX, Wang L, Yaghmour B, Ramshingh G, Yaghmour G. The role of FLT3 inhibitors as maintenance therapy following hematopoietic stem cell transplant. Leuk Res Rep. 2018; 10: 26-36.LiGXWangLYaghmourBRamshinghGYaghmourGThe role of FLT3 inhibitors as maintenance therapy following hematopoietic stem cell transplantLeuk Res Rep201810263610.1016/j.lrr.2018.06.003Search in Google Scholar
Thiede C, Koch S, Creutzig E, Steudel C, Illmer T, Schaich M, et al. Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML). Blood. 2006; 107(10): 4011-4020.ThiedeCKochSCreutzigESteudelCIllmerTSchaichMet alPrevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML)Blood2006107104011402010.1182/blood-2005-08-3167Search in Google Scholar
Geletu M, Balkhi MY, Peer Zada AA Christopeit M, Pulikkan JA, Trivedi AK, et al. Target proteins of C/ EB Pap30 in AML: C/EBPap30 enhances sumoylation of C/EB Pap42 via up-regulation of Ubc9. Blood. 2007; 110(9): 3301-3309.GeletuMBalkhiMYPeerZada AA Christopeit MPulikkanJATrivediAKet alTarget proteins of C/ EB Pap30 in AML: C/EBPap30 enhances sumoylation of C/EB Pap42 via up-regulation of Ubc9Blood200711093301330910.1182/blood-2007-01-071035Search in Google Scholar
Pastore F, Kling D, Hoster E, Dufour A, Konstandin NP, Schneider S, et al. Long-term follow-up of cytogenetically normal CEBPA-mutated AML. J Hematol Oncol. 2014; 7(1): 1-8.PastoreFKlingDHosterEDufourAKonstandinNPSchneiderSet alLong-term follow-up of cytogenetically normal CEBPA-mutated AMLJ Hematol Oncol2014711810.1186/s13045-014-0055-7Search in Google Scholar
Leroy H, Roumier C, Huyghe P, Biggio V, Fenaux P, Preudhomme C. CEBPA point mutations in hematological malignancies. Leukemia. 2005; 19(3): 329-334.LeroyHRoumierCHuyghePBiggioVFenauxPPreudhommeCCEBPA point mutations in hematological malignanciesLeukemia200519332933410.1038/sj.leu.2403614Search in Google Scholar
Hughes JM, Legnini I, Salvatori B, Masciarelli S, Marchioni M, Fazi F, et al. C/EBPα-p30 protein induces expression of the oncogenic long non-coding RNA UCA1 in acute myeloid leukemia. Oncotarget. 2015; 6(21): 18534-18544.HughesJMLegniniISalvatoriBMasciarelliSMarchioniMFaziFet alC/EBPα-p30 protein induces expression of the oncogenic long non-coding RNA UCA1 in acute myeloid leukemiaOncotarget2015621185341854410.18632/oncotarget.4069Search in Google Scholar
Tawana K, Rio-Machin A, Preudhomme C, Fitzgibbon J. Familial CEBPA-mutated acute myeloid leukemia. Semin Hematol. 2017; 54(2): 87-93.TawanaKRio-MachinAPreudhommeCFitzgibbonJFamilial CEBPA-mutated acute myeloid leukemiaSemin Hematol2017542879310.1053/j.seminhematol.2017.04.001Search in Google Scholar
Kim S, Kim DH, Jang JH, Jung CW, Jang MA, Ki CS, et al. Novel mutations in CEBPA in Korean patients with acute myeloid leukemia with a normal karyotype. Ann Lab Med. 2012; 32(2): 153-157.KimSKimDHJangJHJungCWJangMAKiCSet alNovel mutations in CEBPA in Korean patients with acute myeloid leukemia with a normal karyotypeAnn Lab Med201232215315710.3343/alm.2012.32.2.153Search in Google Scholar
Ram J, Flamm G, Balys M, Sivagnanalingam U, Rothberg PG, Iqbal A, et al. Index case of acute myeloid leukemia in a family harboring a novel CEBPA germ line mutation. Blood Adv. 2017; 1(8): 500-503.RamJFlammGBalysMSivagnanalingamURothbergPGIqbalAet alIndex case of acute myeloid leukemia in a family harboring a novel CEBPA germ line mutationBlood Adv20171850050310.1182/bloodadvances.2017004424Search in Google Scholar
